Anemia Evaluation and Management Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Anemia Evaluation and Management. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Anemia Evaluation and Management Indian Medical PG Question 1: Which of the following is a feature of Vit B12 deficiency anemia?
- A. Macro-ovalocytes
- B. All of the options (Correct Answer)
- C. Megaloblastic anemia
- D. Hypersegmented neutrophils
Anemia Evaluation and Management Explanation: **All of the options**
- **Vitamin B12 deficiency anemia** is a type of **megaloblastic anemia** characterized by impaired DNA synthesis, leading to large, immature red blood cells and neutrophils [1].
- The presence of **macro-ovalocytes** and **hypersegmented neutrophils** are classic hematological features seen on a peripheral blood smear [1].
*Macro-ovalocytes*
- **Macro-ovalocytes** are abnormally large, oval-shaped red blood cells, which result from arrested maturation due to the deficiency.
- While a hallmark of B12 deficiency, it is not the sole identifying feature, as other megaloblastic anemias can also present with them [2].
*Megaloblastic anemia*
- **Megaloblastic anemia** is a broad category of anemia characterized by large, immature, and dysfunctional red blood cells, which is the primary classification for B12 deficiency [2].
- While accurate, it doesn't encompass the specific morphological findings seen in the blood smear of B12 deficiency, unlike the other options.
*Hypersegmented neutrophils*
- **Hypersegmented neutrophils** are neutrophils with five or more nuclear lobes, a characteristic sign of impaired DNA synthesis affecting granulopoiesis [1].
- This feature is highly specific to **megaloblastic anemias**, distinguishing them from other causes of macrocytosis.
Anemia Evaluation and Management Indian Medical PG Question 2: Which parameter is primarily used to diagnose macrocytosis in a complete blood count (CBC)?
- A. Hematocrit
- B. Mean Corpuscular Hemoglobin Concentration (MCHC)
- C. Mean Corpuscular Volume (MCV) (Correct Answer)
- D. None of the options
Anemia Evaluation and Management Explanation: ***Mean Corpuscular Volume (MCV)***
- **MCV** measures the **average volume of red blood cells**, making it the primary indicator for classifying them as microcytic, normocytic, or macrocytic.
- An **elevated MCV** (typically above 100 fL) indicates **macrocytosis**, meaning the red blood cells are larger than normal.
*Mean Corpuscular Hemoglobin Concentration (MCHC)*
- **MCHC** reflects the **average concentration of hemoglobin** in red blood cells, primarily used to classify cells as normochromic or hypochromic.
- It does **not directly measure cell size** and therefore is not used to diagnose macrocytosis.
*Hematocrit*
- **Hematocrit** measures the **percentage of red blood cells** in a given volume of blood.
- While it indicates the overall red cell mass, it **does not provide information about the average size** of individual red blood cells.
*None of the options*
- As **MCV** is explicitly listed and is the correct parameter for diagnosing macrocytosis, this option is incorrect.
- The other parameters listed are important for other aspects of red blood cell analysis but not for classifying cell size.
Anemia Evaluation and Management Indian Medical PG Question 3: Earliest manifestation of megaloblastic anemia is
- A. Macrocytosis
- B. Hypersegmented neutrophils (Correct Answer)
- C. Basophilic stippling
- D. Cabot ring
Anemia Evaluation and Management Explanation: ***Hypersegmented neutrophils***
- The earliest manifestation of megaloblastic anemia includes the presence of **hypersegmented neutrophils**, which have more than five lobes in their nuclei [1][2].
- This finding is indicative of impaired DNA synthesis often associated with **vitamin B12** or **folate deficiency**.
*Basophilic stippling*
- **Basophilic stippling** is more commonly linked to lead poisoning and certain alcohol-related disorders rather than megaloblastic anemia.
- It reflects RNA aggregate remnants in red blood cells, which is not a primary feature of this type of anemia.
*Cabot ring*
- **Cabot rings** are seen in conditions like **pernicious anemia** but are not the **earliest manifestation**; they are infrequently encountered.
- This abnormality is related to nuclear remnant material and lacks direct correlation to megaloblastic changes.
*Macrocytosis*
- **Macrocytosis** refers to the increased size of red blood cells and can be found in megaloblastic anemia but is not the **initial manifestation**.
- It may develop later as the anemia progresses, whereas hypersegmented neutrophils appear much earlier.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 593-594.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 654.
Anemia Evaluation and Management Indian Medical PG Question 4: A 35 year old woman presents with fatigue. Investigations revealed the following: Hb, 5 g/dL; MCH, 24; low MCV; leukocytes, 11,000/ uL, and platelets, 5 lakhs. The peripheral smear is shown below. What is the diagnosis?
Normal values:
- Mean cell volume (MCV); 90 ± 8 fL
- Mean cell Hb(MCH); 30 ± 3 pg
- A. Essential thrombocytosis
- B. Iron - deficiency anemia (Correct Answer)
- C. Thalassemia major
- D. Megaloblastic anemia
Anemia Evaluation and Management Explanation: ***Iron-deficiency anemia***
- The patient presents with **severe anemia (Hb 5 g/dL)**, **low MCH (24 pg)**, and **low MCV**, which are classic indicators of **microcytic, hypochromic anemia** [3]. The peripheral smear shows **hypochromic microcytic red cells** with abundant central pallor and **anisopoikilocytosis**, consistent with iron-deficiency anemia [1].
- While the **platelet count is elevated (5 lakhs)**, it can occur in iron deficiency as reactive thrombocytosis [1]. Leukocytosis in the absence of infection may be a mild reactive process secondary to severe anemia.
*Essential thrombocytosis*
- This is a **myeloproliferative neoplasm** characterized by significantly elevated platelet counts (often > 450,000/uL), but typically does not present with severe anemia, low MCH, or low MCV.
- The primary issue in this patient is severe anemia with microcytic hypochromic features, not isolated thrombocytosis.
*Thalassemia major*
- While thalassemia major also presents with **microcytic, hypochromic anemia** and can have a very low MCV, it usually manifests in early childhood and is associated with significant **hemolysis**, **splenomegaly**, and characteristic red blood cell morphology such as **target cells** and **nucleated red blood cells** [2].
- The extremely low Hb and microcytic indices alone are not enough to distinguish it from severe iron deficiency without further specific markers like iron studies or hemoglobin electrophoresis.
*Megaloblastic anemia*
- Megaloblastic anemia is characterized by **macrocytic anemia** (high MCV), which is the opposite of the low MCV presented in this case.
- It typically results from **vitamin B12** or **folate deficiency** and the peripheral smear would show **macro-ovalocytes** and **hypersegmented neutrophils**, which are not seen here.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 590-591.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 648.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 638-639.
Anemia Evaluation and Management Indian Medical PG Question 5: Anemia with reticulocytosis is seen in -
- A. Hemolysis (Correct Answer)
- B. Iron deficiency anemia
- C. Vitamin B12 deficiency
- D. Aplastic anemia
Anemia Evaluation and Management Explanation: ***Hemolysis***
- Reticulocytosis indicates a compensatory response to anemia, often occurring in hemolytic processes where the **bone marrow increases red blood cell production** in response to red blood cell destruction.
- Conditions like **sickle cell disease** or **autoimmune hemolytic anemia** lead to hemolysis, further confirming increased reticulocyte count.
*Iron deficiency anemia*
- Typically presents with a **low reticulocyte count** as the bone marrow does not have sufficient iron to produce new red blood cells.
- This condition is characterized by **microcytic, hypochromic** red blood cells due to inadequate iron stores.
*Vitamin B12 deficiency*
- Often results in a **macrocytic anemia** with a variable reticulocyte count; however, reticulocytosis is generally not seen initially.
- This deficiency affects DNA synthesis, leading to ineffective erythropoiesis and the presence of **megaloblastic changes**.
*Aplastic anemia*
- Characterized by a **decrease in all types of blood cells** (pancytopenia) and typically has a **low reticulocyte count** due to bone marrow failure.
- There is insufficient production of red blood cells, hence **reticulocytosis is not observed**.
Anemia Evaluation and Management Indian Medical PG Question 6: A patient has MCV <80, MCH <23. Which type of anaemia shall be classified?
- A. Microcytic hypochromic (Correct Answer)
- B. Normocytic normochromic
- C. Normocytic hypochromic
- D. Hyperchromic macrocytic
Anemia Evaluation and Management Explanation: ***Microcytic hypochromic***
- A **Mean Corpuscular Volume (MCV)** less than **80 fL** indicates **microcytosis** (small red blood cells) [1].
- A **Mean Corpuscular Hemoglobin (MCH)** less than **23 pg** indicates **hypochromia** (pale red blood cells due to reduced hemoglobin content) [1].
*Normocytic normochromic*
- This classification refers to red blood cells with **normal MCV (80-100 fL)** and **normal MCH (27-32 pg)**.
- Examples include anemia of chronic disease or acute blood loss, which do not fit the given lab values.
*Normocytic hypochromic*
- While **hypochromia (MCH <23)** is present, the **MCV is less than 80 fL**, which makes it microcytic, not normocytic.
- This combination is not a standard classification; hypochromia typically accompanies microcytosis [1].
*Hyperchromic macrocytic*
- **Macrocytic anemia** is characterized by an **MCV >100 fL**, which is the opposite of the given MCV of <80.
- The term "hyperchromic" is generally not used for anemia classification because red blood cells have a maximal hemoglobin concentration and cannot be truly hyperchromic.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 590-591.
Anemia Evaluation and Management Indian Medical PG Question 7: What is a known complication of Parvovirus B19 infection?
- A. Erythema infectiosum
- B. Arthritis
- C. Aplastic anemia (Correct Answer)
- D. All of the options
Anemia Evaluation and Management Explanation: Aplastic anemia
- Parvovirus B19 has a tropism for erythroid progenitor cells in the bone marrow, specifically targeting and destroying them [1].
- This destruction can lead to a transient aplastic crisis, especially in individuals with pre-existing hemolytic conditions, causing a severe drop in red blood cell production [1].
Erythema infectiosum
- This is the most common clinical manifestation of Parvovirus B19 infection, also known as fifth disease, characterized by a "slapped cheek" rash [1].
- While it is a symptom or disease caused by the virus, it is not considered a complication in the sense of a secondary, adverse outcome.
Arthritis
- Arthralgia and arthritis are common manifestations of Parvovirus B19 infection, particularly in adults, especially women [1].
- Similar to erythema infectiosum, it is a direct clinical manifestation rather than a "complication" representing a secondary, undesirable event.
All of the options
- While erythema infectiosum and arthritis are common clinical presentations of Parvovirus B19, they are direct disease manifestations.
- Aplastic anemia stands out as a true complication, representing a secondary and potentially severe adverse outcome due to the virus's specific cellular tropism [1].
Anemia Evaluation and Management Indian Medical PG Question 8: Which of the following is not likely to be seen in a patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)?
- A. Thrombosis
- B. Aplastic anemia
- C. Leukemia (Correct Answer)
- D. Hemolysis
Anemia Evaluation and Management Explanation: Leukemia
- While PNH can transform into **acute myeloid leukemia (AML)** in a small percentage of cases, it is not a common or direct presentation, making it the *least likely* immediate finding among the options.
- The primary pathophysiology of PNH involves a defect in hematopoietic stem cells leading to complement-mediated destruction, not malignant proliferation of myeloid or lymphoid cells as seen in leukemia.
*Thrombosis*
- **Thrombosis** is a major cause of morbidity and mortality in PNH, occurring due to complement activation and platelet activation on the surface of GPI-deficient cells.
- It most commonly affects unusual sites like the **hepatic** or **mesenteric veins**, and cerebral venous sinuses.
*Aplastic anemia*
- **Aplastic anemia** is closely associated with PNH, as both with conditions can arise from a defect in hematopoietic stem cells.
- PNH clones are often detectable in patients with aplastic anemia, and some cases of PNH evolve from or into aplastic anemia.
*Hemolysis*
- **Hemolysis** is a hallmark of PNH, caused by the absence of **GPI-anchored proteins (CD55 and CD59)** on red blood cells, making them susceptible to complement-mediated destruction [1].
- This leads to intravascular hemolysis, resulting in characteristic symptoms like **dark urine** (hemoglobinuria), especially in the morning [1].
Anemia Evaluation and Management Indian Medical PG Question 9: Bleeding crisis in acute idiopathic thrombo-cytopenic purpura is managed by all except -
- A. Intravenous immunoglobulin
- B. Prednisolone
- C. Eltrombopag (Correct Answer)
- D. RhIG
Anemia Evaluation and Management Explanation: ***Eltrombopag***
- **Eltrombopag** is a **thrombopoietin receptor agonist** used for chronic idiopathic thrombocytopenic purpura (ITP) to increase platelet production.
- It is **not** used for the immediate management of an acute bleeding crisis, as its effects on platelet counts take several days to manifest.
*Intravenous immunoglobulin*
- **Intravenous immunoglobulin (IVIG)** works by blocking **Fc receptors** on macrophages, thereby reducing the destruction of antibody-coated platelets.
- It is a **first-line treatment** for acute ITP, especially in cases with severe bleeding or very low platelet counts, providing a rapid increase in platelet count.
*Prednisolone*
- **Prednisolone**, a corticosteroid, is a **first-line treatment** for acute ITP, as it suppresses the immune system and reduces antibody production and platelet destruction.
- It helps to quickly raise platelet counts and is effective in managing bleeding episodes, though its effects are not as immediate as IVIG.
*RhIG*
- **Rh immune globulin (RhIG)** is used in **Rh-positive** patients with ITP to cause a transient hemolytic anemia, which occupies splenic macrophages and reduces platelet destruction.
- It `is an effective option` for acute ITP, particularly in patients who require a rapid increase in platelet count and are Rh-positive.
Anemia Evaluation and Management Indian Medical PG Question 10: A 40-year-old presents with cirrhosis and low ferritin. What is the next step in management?
- A. Iron supplements (Correct Answer)
- B. Phlebotomy
- C. Liver biopsy
- D. Transfusion
Anemia Evaluation and Management Explanation: ***Iron supplements***
- **Cirrhosis** can lead to **malnutrition** and **impaired iron absorption**, resulting in **iron deficiency anemia**. [2]
- **Low ferritin** in a patient with cirrhosis directly indicates **iron deficiency**, making iron supplementation the appropriate initial step to replete iron stores. [3]
*Phlebotomy*
- **Phlebotomy** is indicated in conditions of **iron overload**, such as **hemochromatosis**, where ferritin levels would be high, not low. [1]
- Doing this in a patient with **iron deficiency** would worsen their anemia and be detrimental.
*Liver biopsy*
- A **liver biopsy** is typically performed to diagnose the cause or assess the stage of **liver disease**, or to evaluate for **liver masses**. [1]
- It is not indicated as the next step specifically for **low ferritin** in cirrhosis, as the cause of low ferritin (iron deficiency) is evident and manageable.
*Transfusion*
- **Blood transfusion** is reserved for patients with severe, **symptomatic anemia** or acute bleeding, where rapid correction of hemoglobin is necessary.
- In a patient with **low ferritin** but no mention of severe anemia symptoms, iron supplementation is the first-line treatment.
More Anemia Evaluation and Management Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
